A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies	Gynecological Malignancies	Recruiting	Phase 1 / Phase 2	2025-09-26		NCT06131450

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.	110
Sichuan Baili Pharmaceutical Co., Ltd.	135

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer hospital, Chinese Academy of Medical Sciences	Beijing	China	12

Clinical trials